TG Therapeutics, Inc. (TGTX) Profit Margins
Over the twelve months to 2026-06-30, TG Therapeutics, Inc. (TGTX) had gross margin 82.4%, operating margin 17.1%, net margin 55.2%, free cash flow margin 2.2%, according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
TGTXTG Therapeutics, Inc.Follow TGTX — free
—
Price chart with a free account
- Market cap
- 8.3B
- P/E TTM
- 19.7
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 9 Nov, in 16 days
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | — | — | — | — | — | 94.0% | 88.3% | 83.7% | 82.4% | |
| Operating margin | -114736.8% | -111220.4% | -179996.1% | -5154.3% | -7839.0% | 8.8% | 12.7% | 20.0% | 17.1% | |
| Net margin | -114132.9% | -113730.9% | -183803.3% | -5204.1% | -8036.3% | 5.4% | 7.1% | 72.6% | 55.2% | |
| FCF margin | -84878.3% | -87458.6% | -141357.9% | -4425.7% | -6326.2% | -13.4% | -12.3% | -4.1% | 2.2% |
USD billions · SEC XBRL
TG Therapeutics, Inc. — questions
- What is TG Therapeutics, Inc.'s gross margin?
- 82.4% over the twelve months to 2026-06-30.
- What is TG Therapeutics, Inc.'s operating margin?
- 17.1% over the twelve months to 2026-06-30.
- What is TG Therapeutics, Inc.'s net profit margin?
- 55.2% over the twelve months to 2026-06-30.
Every figure on this page comes from TG Therapeutics, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.